NEUROELECTRICS BARCELONA SL

Their core work

Neuroelectrics develops non-invasive brain stimulation technology and digital twin models for neurological and neuropsychiatric conditions. They build personalized computational models of brain activity to optimize transcranial electrical stimulation therapies for conditions including epilepsy, Alzheimer's disease, ADHD, and autism spectrum disorders. Their work bridges neuroscience modeling with clinical application, turning biophysical brain simulations into treatment planning tools. As a Barcelona-based SME, they operate at the intersection of medical device development and computational neuroscience.

What they specialise in

How they've shifted over time

Their early H2020 work (2017, STIPED) centered on applying transcranial direct current stimulation to pediatric conditions like ADHD and autism, with a focus on biomarkers and basic modeling. From 2020 onward, their projects shifted decisively toward computational sophistication — personalized biophysical brain models, signal processing optimization, and the digital twin concept (GALVANI, Neurotwin). The trajectory shows a company moving from clinical application of existing stimulation techniques toward building the computational infrastructure that makes stimulation personalized and precise.

Neuroelectrics is moving toward AI-driven, patient-specific brain stimulation planning — expect future work in digital twin therapeutics and closed-loop neuromodulation systems.

How they like to work

Neuroelectrics operates primarily as a specialized technology partner, joining as participant in 2 of 3 projects and coordinating 1 (Neurotwin). Their coordinator role in Neurotwin — an SME-led innovation project — signals growing confidence in leading consortia, not just contributing. With 24 unique partners across 8 countries in only 3 projects, they work in medium-to-large consortia and are clearly comfortable integrating into diverse international teams.

Across just 3 projects, they have built a network of 24 unique partners in 8 countries, suggesting they consistently join well-connected, multi-country consortia rather than small bilateral collaborations. Their base in Barcelona positions them within Spain's strong neuroscience ecosystem while maintaining broad European reach.

What sets them apart

Neuroelectrics occupies a rare niche as an SME that combines medical device capability with deep computational neuroscience — most companies in brain stimulation are either pure hardware manufacturers or academic spin-offs without product development muscle. Their digital twin approach to treatment planning (Neurotwin) positions them ahead of competitors still relying on one-size-fits-all stimulation protocols. For consortium builders, they bring both the modeling expertise and the commercial pathway to translate research into a regulated medical product.

Highlights from their portfolio

• GALVANI
  Largest single project (EUR 2.9M to Neuroelectrics) under a prestigious ERC Synergy Grant, running until 2027 — signals deep scientific credibility in computational neuromodulation.
• Neurotwin
  Their first coordinator role, focused on digital twins for brain stimulation — represents the company stepping up from contributor to project leader with a commercially promising concept.
• STIPED
  Their entry into H2020, applying brain stimulation to pediatric ADHD and autism — demonstrates clinical translation capability beyond pure research.